Ligand Pharmaceuticals (LGND) Q4 EPS of $0.27 beats by $0.06. Revenue of $13.6M beats by $0.3M. (PR)

|About: Ligand Pharmaceuticals I... (LGND)|By:, SA News Editor
Ligand Pharmaceuticals (LGND) Q4 EPS of $0.27 beats by $0.06. Revenue of $13.6M beats by $0.3M. (PR)